Giant Biogene Holding Co., Ltd. announced that it has received investment in a round of funding in 2021. The transaction included participation from new investor Legend Capital Management Co., Ltd.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
49.15 HKD | -1.50% | -4.01% | +37.92% |
05-27 | Giant Biogene Places 33.2 Million Shares for About HK$1.63 | MT |
04-30 | Giant Biogene’s Profit Up 47% in 2023 | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.92% | 6.45B | |
+10.31% | 382B | |
+14.53% | 74.9B | |
-11.75% | 66.87B | |
-16.89% | 43.58B | |
-12.35% | 36.13B | |
+6.34% | 34.76B | |
+7.68% | 17.67B | |
+13.73% | 15.95B | |
-0.64% | 11.81B |
- Stock Market
- Equities
- 2367 Stock
- News Giant Biogene Holding Co., Ltd.
- Giant Biogene Holding Co., Ltd. announced that it has received funding from Legend Capital Management Co., Ltd.